Team:Paris Bettencourt/Human Practice/Overview
From 2012.igem.org
(Difference between revisions)
Line 5: | Line 5: | ||
<tr> | <tr> | ||
<td> | <td> | ||
- | Aim | + | |
+ | '''''Aim''''' | ||
To chart new venues of best practice for synthetic biology. To this end, we examined the ethical, biological and social concerns related to the release of genetically modified bacteria in the wild. | To chart new venues of best practice for synthetic biology. To this end, we examined the ethical, biological and social concerns related to the release of genetically modified bacteria in the wild. | ||
- | Metodology | + | '''''Metodology''''' |
#Interviews with experts which enabled us to have a broad overview of the state of the art. [https://2012.igem.org/Team:Paris_Bettencourt/Human_Practice/Interview Read More] | #Interviews with experts which enabled us to have a broad overview of the state of the art. [https://2012.igem.org/Team:Paris_Bettencourt/Human_Practice/Interview Read More] | ||
#We screened previous iGEM team’s wikis to trace the evolution of biosafety concerns in the iGEM competition when it comes to releasing genetically modified bacteria in the wild. We especially examined the containment systems that have been proposed. [https://2012.igem.org/Team:Paris_Bettencourt/Human_Practice/WikiScreen Read More] | #We screened previous iGEM team’s wikis to trace the evolution of biosafety concerns in the iGEM competition when it comes to releasing genetically modified bacteria in the wild. We especially examined the containment systems that have been proposed. [https://2012.igem.org/Team:Paris_Bettencourt/Human_Practice/WikiScreen Read More] | ||
Line 14: | Line 15: | ||
#: We set the bar for risk at horizontal gene transfer. Therefore HGT is what we are trying to prevent. | #: We set the bar for risk at horizontal gene transfer. Therefore HGT is what we are trying to prevent. | ||
- | Main Conclusions | + | '''''Main Conclusions''''' |
# Society interaction: | # Society interaction: | ||
#:*The need to raise awareness of synthetic biology in the population so people can decide in the most enlightened way possible if they want of this new technology and of its applications (A), | #:*The need to raise awareness of synthetic biology in the population so people can decide in the most enlightened way possible if they want of this new technology and of its applications (A), | ||
Line 24: | Line 25: | ||
#:* The compiling of the wiki screen shows that no containment systems created in iGEM is robust: they are all one mutation away from failure. We call for more biosafety in iGEM (F), | #:* The compiling of the wiki screen shows that no containment systems created in iGEM is robust: they are all one mutation away from failure. We call for more biosafety in iGEM (F), | ||
#:* The need for an INDEPENDENT committee of scientists to test any application of synthetic biology that requires releasing in the environment (G), | #:* The need for an INDEPENDENT committee of scientists to test any application of synthetic biology that requires releasing in the environment (G), | ||
- | You can find the full list [https://2012.igem.org/Team:Paris_Bettencourt/Human_Practice/Report here] | + | You can find the full list [https://2012.igem.org/Team:Paris_Bettencourt/Human_Practice/Report here] |
- | Main Proposals | + | '''''Main Proposals''''' |
# Society interaction: | # Society interaction: | ||
#:* Organizing a workshop on synthetic biology and a tour of our lab for 60high school students, (addresses issue A and B) [https://2012.igem.org/Team:Paris_Bettencourt/Human_Practice/Workshop Read More]. Ultimately, we would like interaction with high school or middle school students to be a requirement for an iGEM gold medal. | #:* Organizing a workshop on synthetic biology and a tour of our lab for 60high school students, (addresses issue A and B) [https://2012.igem.org/Team:Paris_Bettencourt/Human_Practice/Workshop Read More]. Ultimately, we would like interaction with high school or middle school students to be a requirement for an iGEM gold medal. | ||
Line 33: | Line 34: | ||
#:* Creating a system as robust as possible, that is many mutations away from failure (this is what all our bench work has been about) (addresses issue C and F), | #:* Creating a system as robust as possible, that is many mutations away from failure (this is what all our bench work has been about) (addresses issue C and F), | ||
#:* Creating a safety page on the biobrick registry where all the safety devices that exist are listed and characterized (included evaluation of their robustness) in order for iGEM teams to pick the most appropriate device to add to their newly created genetic circuit. Ultimately, we would like the integration of a safety device (already listed in the safety page or created de novo by the team) to be a requirement for an iGEM bronze medal (addresses issue D, F), [http://partsregistry.org/Biosafety Go to safety page] | #:* Creating a safety page on the biobrick registry where all the safety devices that exist are listed and characterized (included evaluation of their robustness) in order for iGEM teams to pick the most appropriate device to add to their newly created genetic circuit. Ultimately, we would like the integration of a safety device (already listed in the safety page or created de novo by the team) to be a requirement for an iGEM bronze medal (addresses issue D, F), [http://partsregistry.org/Biosafety Go to safety page] | ||
- | #:* Making a list of | + | #:* Making a list of [https://2012.igem.org/Team:Paris_Bettencourt/Human_Practice/Report#IV_Proposals proposals] |
</td> | </td> |
Revision as of 22:01, 26 September 2012
Human Practice
Aim To chart new venues of best practice for synthetic biology. To this end, we examined the ethical, biological and social concerns related to the release of genetically modified bacteria in the wild. Metodology
Main Conclusions
You can find the full list here Main Proposals
|